tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LXRX Stock Latest News

Lexicon Pharmaceuticals Faces Supply Chain Risks Amidst Changing Trade Policies
Company AnnouncementsLexicon Pharmaceuticals Faces Supply Chain Risks Amidst Changing Trade Policies
19d ago
LXRX
Vistra, Ardelyx, Zscaler, Lexicon, Arista: Trending by Analysts
PremiumWeekend Updates
Vistra, Ardelyx, Zscaler, Lexicon, Arista: Trending by Analysts
20d ago
ZS
VST
Lexicon Pharmaceuticals’ Mixed Earnings Call: Achievements and Challenges
PremiumCompany Announcements
Lexicon Pharmaceuticals’ Mixed Earnings Call: Achievements and Challenges
20d ago
LXRX
Lexicon price target lowered to $6 from $10 at Piper Sandler
PremiumThe Fly
Lexicon price target lowered to $6 from $10 at Piper Sandler
21d ago
LXRX
Lexicon Pharmaceuticals Advances Pipeline Amid Financial Growth
PremiumCompany Announcements
Lexicon Pharmaceuticals Advances Pipeline Amid Financial Growth
21d ago
LXRX
Lexicon reports Q4 EPS (9c), consensus (12)
PremiumThe FlyLexicon reports Q4 EPS (9c), consensus (12)
22d ago
LXRX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
22d ago
ADMA
ALDX
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
22d ago
TH
BHP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
23d ago
ALDX
ANRO
Lexicon Pharmaceuticals Faces Uncertain Future Amidst Modest Trial Results and Competitive Pressures
PremiumRatings
Lexicon Pharmaceuticals Faces Uncertain Future Amidst Modest Trial Results and Competitive Pressures
24d ago
LXRX
Lexicon downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Lexicon downgraded to Market Perform from Outperform at Leerink
24d ago
LXRX
Lexicon Pharmaceuticals’ Promising Phase 2b Trial Results for Pilavapadin Drive Buy Rating
PremiumRatings
Lexicon Pharmaceuticals’ Promising Phase 2b Trial Results for Pilavapadin Drive Buy Rating
25d ago
LXRX
Lexicon announces PROGRESS Phase 2b study results for 10mg, 20mg
PremiumThe FlyLexicon announces PROGRESS Phase 2b study results for 10mg, 20mg
25d ago
LXRX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ADTX
ARDX
Lexicon’s sotagliflozin shows cardiovascular efficacy in published study
Premium
The Fly
Lexicon’s sotagliflozin shows cardiovascular efficacy in published study
1M ago
LXRX
Lexicon rumor highlighted in Betaville alert
PremiumThe Fly
Lexicon rumor highlighted in Betaville alert
2M ago
LXRX
Lexicon Pharmaceuticals Appoints New CFO Scott M. Coiante
PremiumCompany Announcements
Lexicon Pharmaceuticals Appoints New CFO Scott M. Coiante
3M ago
8K
LXRX
Lexicon appoints Scott Coiante as CFO
PremiumThe Fly
Lexicon appoints Scott Coiante as CFO
3M ago
LXRX
Lexicon receives CRL for Zynquista
PremiumThe Fly
Lexicon receives CRL for Zynquista
3M ago
LXRX
Lexicon price target lowered to $1.20 from $4 at Citi
PremiumThe FlyLexicon price target lowered to $1.20 from $4 at Citi
4M ago
LXRX
Lexicon announces completion of enrollment in Phase 2B PROGRESS study
Premium
The Fly
Lexicon announces completion of enrollment in Phase 2B PROGRESS study
4M ago
LXRX
Lexicon price target lowered to $4 from $6 at H.C. Wainwright
Premium
The Fly
Lexicon price target lowered to $4 from $6 at H.C. Wainwright
4M ago
LXRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >